Global Hemophilia B Market: Overview

Hemophilia B is a bleeding disorder characterized by a lack of blood clotting factor IX. Factor IX is an important coagulation factor that is necessary for blood clotting, and it helps control bleeding. The process of blood clot formation is known as coagulation cascade, which uses clotting factors or coagulation factors. The disorder is caused by inherited X-linked recessive trait, a defected gene located on the X chromosome.

Global Hemophilia B Market: Key Trends

The hemophilia B treatment market is anticipated to expand at a significant growth rate due to factors such as recent product launches, increase in the number of regulatory approvals, and rise in demand for recombinant coagulation factors concentrates for the treatment of hemophilia B. For instance, in February 2018, Novo Nordisk A/S launched Rebinyn in the U.S. for the treatment of Hemophilia B thereby expending its product portfolio for rare disease treatment. In March 2014, Bioverativ Therapeutics, Inc. received FDA approval for Alprolix , a recombinant factor IX indicated for the treatment of hemophilia B. This enabled the company to cater to the needs of patients affected by hemophilia B. The launch of this drug offered a competition advantage to the company, increasing its share in the market. Further, promising drugs in the pipeline and increase in research and development (R&D) expenditure on the treatment of rare hematological disease are anticipated to support the growth of the market during the forecast period.

Global Hemophilia B Market: Segmentation

The global hemophilia B market can be segmented based on product, distribution channel, and region. In terms of product, the market can be divided into recombinant coagulation factor concentrates, plasma-derived coagulation factor concentrates, and others. The recombinant coagulation factor concentrates segment is anticipated to expand at a rapid CAGR during the forecast period, due to a shift from the use of plasma-derived coagulation factor concentrates to recombinant factors and increase in the availability of recombinant factors for the treatment of hemophilia B. In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to hold a key market share, owing to a rise in investments in the rare disease management sectors by hospitals in emerging countries such as China, Japan, and other countries in Asia Pacific.

Global Hemophilia B Market: Regional Analysis

Based on region, the global hemophilia B market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for a prominent market share during the forecast period. The market in the region is driven by an increase in the number of mergers & acquisitions, agreements & partnerships, and other strategic approaches by market players and FDA approvals for recombinant coagulation factor concentrates. In Europe, the hemophilia B market is expected to be driven the introduction of recombinant therapies, rapid adoption of recombinant DNA technologies, and increase in R&D activities by market players. In Germany and the U.K., recombinant plasma protein therapeutics have received significant importance due to an increase commercial players offering products for hemophilia B and a high number of hemophilia patients treated with recombinant products. The market in Asia Pacific is expected to expand at the rapid CAGR during the forecast period, driven by an increase in the number of awareness campaigns regarding rare hematological disorders, geographical expansion by market players, and increase in the demand or novel therapies for the treatment of hemophilia B. In China and Japan, regulatory authorities have recently approved various recombinant plasma protein concentrates that have helped increase their availability in these countries.

Global Hemophilia B Market: Competitive Landscape

 Key players operating in the global hemophilia B market are Grifols, S.A., CSL Limited, Shire, Novo Nordisk A/S, Bioverativ Therapeutics, Inc., an affiliate of Sanofi, Pfizer Inc., Kedrion S.p.A, F. Hoffmann-La Roche Ltd., Aptevo Therapeutics, and Baxter.

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

The study presents scrutiny of region-specific consumer and technology trends, including the most recent industry dynamics. These broadly cover but not limited to

  • North America, South America, and the Americas
  • Asia Pacific and Japan
  • Europe
  • Latin America
  • Middle East and Africa

The study offers data-driven insights and guidance of several aspects. Some of the more notable questions are:

  • What are the major recent trends that can influence the product life cycle and the RoI?
  • Which regulatory trends shape corporate-level, business-level, and functional-level strategies?
  • Which micromarketing initiatives of leading players will bring in investments?
  • What can be the best framework and tools for PESTLE analysis?
  • Which regions will witness rise in new opportunities?
  • Which are the game-changing technologies being used to capture new revenue streams in the near future?
  • Which operational and tactical frameworks are being adopted by various players in gaining customer loyalty?
  • What is the current and expected intensity of competition the market in the near future?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Disclaimer: This market research study is an ongoing effort and extreme care has been taken to maintain the highest levels of accuracy at all stages. However, in the light of the rapidly evolving business dynamics, some region-specific or other segment-specific changes may take time to be part of the study.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Hemophilia B Market